Iron Triangle Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-973,057	Closed	-$23.2M	–	35
2024 Q1	$23.2M	Buy	+973,057	New	+$23.2M	2.37%	20
2023 Q1	–	Sell	-370,294	Closed	-$9.42M	–	34
2022 Q4	$9.42M	Buy	+370,294	New	+$9.42M	1.69%	21